drugset / Trial / NCT00165724

Alzheimer's Disease Long-term Follow-up Study (ALF Study)

NCT00165724

Phase 4 Completed 114 enrolled Eisai Co., Ltd.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Open study for efficacy and safety of donepezil treatment during 48 weeks

Timeline

Start
2004-06-30
Primary completion
2006-07-31
Completion
2006-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule

Indications